Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

9DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 32426-57-6, Lysergide d-tartrate, D-lsd 25 bitartrate, 7wnp51ka7m, Lysergide tartrate, Ergoline-8-beta-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, tartrate (1:1), d-

Molecular Formula

C₂₄H₃₁N₃O₇

Molecular Weight

473.5 g/mol

InChI Key

HQMPRARIZOUKRO-JDQBHMBOSA-N

FDA UNII

7WNP51KA7M

1 2D Structure

Lysergide D-tartrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2S,3S)-2,3-dihydroxybutanedioic acid

2.1.2 InChI

InChI=1S/C20H25N3O.C4H6O6/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14;5-1(3(7)8)2(6)4(9)10/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t14-,18-;1-,2-/m10/s1

2.1.3 InChI Key

HQMPRARIZOUKRO-JDQBHMBOSA-N

2.1.4 Canonical SMILES

CCN(CC)C(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C.C(C(C(=O)O)O)(C(=O)O)O

2.1.5 Isomeric SMILES

CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C.[C@H]([C@@H](C(=O)O)O)(C(=O)O)O

2.2 Other Identifiers

2.2.1 UNII

7WNP51KA7M

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 32426-57-6

2. Lysergide D-tartrate

3. D-lsd 25 Bitartrate

4. 7wnp51ka7m

5. Lysergide Tartrate

6. Ergoline-8-beta-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, Tartrate (1:1), D-

7. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;(2s,3s)-2,3-dihydroxybutanedioic Acid

8. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;2,3-dihydroxybutanedioic Acid

9. D-9,10-didehydro-n,n-diethyl-6-methylergoline-8-beta-carboxamide Tartrate (1:1)

10. Unii-7wnp51ka7m

11. Lsd D-(-)-tartrate

12. Lsd (d-tartrate) (solution)

13. Akos040752817

14. Ls-64353

15. Lysergic Acid Diethylamide D-tartrate

16. D-lysergic Acid Diethylamide D-tartrate

17. Q27268952

18. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (2s,3s)-2,3-dihydroxybutanedioate (1:1)

19. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (s-(r*,r*))-2,3-dihydroxybutanedioate (1:1)

20. Ergoline-8.beta.-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (-)-tartrate (1:1)

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₃₁N₃O₇
Molecular Weight	473.5 g/mol
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	6
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	154
Heavy Atom Count	34
Formal Charge	0
Complexity	661
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2